Evaluation of the association between eosinophil variability and effects of inhaled corticosteroids in COPD patients using propensity score matching
J. YOON (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), E. Heo (Seoul, Republic of Korea), H. Chung (Seoul, Republic of Korea), C. Lee (Seoul, Republic of Korea), H. Yoon (Seongnam, Republic of Korea), Y. Hwang (Anyang, Republic of Korea), C. Rhee (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), D. Kim (Seoul, Republic of Korea)
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Disease area: Airway diseases

Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. YOON (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), E. Heo (Seoul, Republic of Korea), H. Chung (Seoul, Republic of Korea), C. Lee (Seoul, Republic of Korea), H. Yoon (Seongnam, Republic of Korea), Y. Hwang (Anyang, Republic of Korea), C. Rhee (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), D. Kim (Seoul, Republic of Korea). Evaluation of the association between eosinophil variability and effects of inhaled corticosteroids in COPD patients using propensity score matching. 3372
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: